HILS insider filings
Hillstream BioPharma Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-13. Screen HILS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for HILS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Hillstream BioPharma Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-13 | 4/A | MILBY RANDY — Chief Executive Officer, Director, 10% owner | Grant/award (A): 515,127 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | MILBY RANDY — Chief Executive Officer, Director, 10% owner | Grant/award (A): 621,795 (derivative) @ $0 | EDGAR |
| 2022-07-18 | 4 | Appajosyula Sireesh — Director | Gift (G): 75,757 @ $0 · Gift (G): 7,576 @ $0 | EDGAR |
| 2022-06-21 | 4 | MILBY RANDY — Chief Executive Officer, Director, 10% owner | Purchase (P): 500 @ $0.78 | EDGAR |
| 2022-06-07 | 4 | MILBY RANDY — Chief Executive Officer, Director | Purchase (P): 234 @ $0.68 · Purchase (P): 100 @ $0.67 · Purchase (P): 100 @ $0.67 · Purchase (P): 66 @ $0.67 · Purchase (P): 500 @ $0.70 | EDGAR |
| 2022-06-02 | 4 | MILBY RANDY — Chief Executive Officer, Director | Purchase (P): 1 @ $0.94 | EDGAR |
| 2022-05-25 | 4 | MILBY RANDY — Chief Executive Officer, Director | Purchase (P): 200 @ $0.77 · Purchase (P): 800 @ $0.79 | EDGAR |
| 2022-05-23 | 4 | MILBY RANDY — Chief Executive Officer, Director | Purchase (P): 500 @ $0.89 · Purchase (P): 500 @ $0.95 | EDGAR |
| 2022-05-19 | 4 | MILBY RANDY — Chief Executive Officer, Director | Purchase (P): 500 @ $0.92 · Purchase (P): 500 @ $0.90 | EDGAR |
| 2022-04-19 | 4 | MILBY RANDY — Chief Executive Officer, Director | Option exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 189,393 @ $0.08 · Option exercise/expiry (X): 28,408 @ $0.08 · Option exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 7,575 (derivative) @ $0 · +4 more | EDGAR |
| 2022-03-23 | 4 | Appajosyula Sireesh — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Bui Lynne A. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Mazur Leonard L — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | MILBY RANDY — Chief Executive Officer, Director | Conversion (C): 8,101 @ $3.20 · Conversion (C): 11,325 @ $3.20 · Conversion (C): 3,231 @ $3.20 · Conversion (C): 11,545 @ $3.20 · Conversion (C): 29,026 @ $3.20 · Conversion (C): 28,366 @ $3.20 · +23 more | EDGAR |
| 2022-01-20 | 4 | MILBY RANDY — Chief Executive Officer, Director | Conversion (C): 14,942 @ $3.20 · Conversion (C): 23,205 @ $3.20 · Conversion (C): 406 @ $3.20 · Conversion (C): 23,187 @ $3.20 · Conversion (C): 16,528 @ $3.20 · Conversion (C): 15,824 @ $3.20 · +24 more | EDGAR |
| 2022-01-20 | 4 | MILBY RANDY — Chief Executive Officer, Director | Conversion (C): 27,479 @ $3.20 · Conversion (C): 30,772 @ $3.20 · Conversion (C): 678 @ $3.20 · Conversion (C): 10,184 @ $3.20 · Conversion (C): 18,637 @ $3.20 · Conversion (C): 18,634 @ $3.20 · +22 more | EDGAR |
| 2022-01-18 | 4 | Mazur Leonard L — Director | Conversion (C): 98,733 @ $3.20 · Purchase (P): 25,000 @ $4 · Conversion (C) @ $0 | EDGAR |
Recent 8-K events — Hillstream BioPharma Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-29 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HILS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs